Ryan Overland

1.0k total citations
12 papers, 842 citations indexed

About

Ryan Overland is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ryan Overland has authored 12 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ryan Overland's work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Ryan Overland is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Ryan Overland collaborates with scholars based in United States, Italy and Spain. Ryan Overland's co-authors include Ghazaleh Sadri‐Vakili, Eva Xia, Ulrik B. Nielsen, Violette Paragas, Charlotte F. McDonagh, J. Jang‐Ho, Andrew R. Hallahan, James M. Olson, Roshantha A.S. Chandraratna and Richard G. Ellenbogen and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Ryan Overland

12 papers receiving 823 citations

Peers

Countries citing papers authored by Ryan Overland

Since Specialization

Citations

This map shows the geographic impact of Ryan Overland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Overland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Overland more than expected).

Fields of papers citing papers by Ryan Overland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Overland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Overland. The network helps show where Ryan Overland may publish in the future.

Co-authorship network of co-authors of Ryan Overland

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Overland. A scholar is included among the top collaborators of Ryan Overland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Overland. Ryan Overland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Preclinical activity of MM-111, a bispecific ErbB2/ErbB3 antibody in previously treated ErbB2-positive gastric and gastroesophageal junction cancer. 2013 ·Journal of Clinical Oncology ·Johanna Lahdenranta, Violette Paragas, Arthur J. Kudla, Ryan Overland, Victor Moyo, Ulrik B. Nielsen, Charlotte F. McDonagh, Matthew Onsum	3
2	Computational Modeling of ERBB2 -Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors 2013 ·Science Signaling ·Daniel C. Kirouac, (unknown), Johanna Lahdenranta, Ryan Overland, Defne Yarar, Violette Paragas, Emily Pace, Charlotte F. McDonagh, Ulrik B. Nielsen, Matthew Onsum	85
3	Abstract 4633: MM-111, a bispecific HER2 and HER3 antibody, synergistically combines with trastuzumab and paclitaxel in preclinical models of gastric cancer. 2013 ·Cancer Research ·Bo Zhang, Johanna Lahdenranta, Jinyan Du, Daniel C. Kirouac, Stephanie A. Nguyen, Ryan Overland, Violette Paragas, Arthur J. Kudla, Ulrik B. Nielsen, Charlotte F. McDonagh, Matthew Onsum	9
4	Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3 2012 ·Molecular Cancer Therapeutics ·Charlotte F. McDonagh, Alexandra Huhalov, Brian D. Harms, Sharlene Adams, Violette Paragas, (unknown), Bo Zhang, Lia Luus, Ryan Overland, Stephanie A. Nguyen, Jinming Gu, Neeraj Kohli, (unknown), Michael J. Feldhaus, Arthur J. Kudla, Birgit Schoeberl, Ulrik B. Nielsen	222
5	Abstract 655: Combination of MM-111, an ErbB2/ErbB3 bispecific antibody, with endocrine therapies as an effective strategy for treatment of ER+/HER2+ breast cancer 2011 ·Cancer Research ·Bo Zhang, Alexandra Huhalov, Olga Burenkova, Sharlene Adams, Stephanie A. Nguyen, Ryan Overland, Arthur J. Kudla, Ulrik B. Nielsen, Clet Niyikiza, Charlotte F. McDonagh, Gavin MacBeath	1
6	Abstract 654: MM-111, an ErbB2/ErbB3 bispecific antibody, effectively combines with lapatinib to inhibit growth of ErbB2-overexpressing tumor cells 2011 ·Cancer Research ·(unknown), Violette Paragas, Sharlene Adams, Lia Luus, Alexandra Huhalov, Arthur J. Kudla, Ryan Overland, Ulrik B. Nielsen, Clet Niyikiza, Charlotte F. McDonagh, Gavin MacBeath	1
7	Cocaine-Induced Chromatin Remodeling Increases Brain-Derived Neurotrophic Factor Transcription in the Rat Medial Prefrontal Cortex, Which Alters the Reinforcing Efficacy of Cocaine 2010 ·Journal of Neuroscience ·Ghazaleh Sadri‐Vakili, Vidhya Kumaresan, Heath D. Schmidt, Katie R. Famous, (unknown), Fair M. Vassoler, Ryan Overland, Eva Xia, Caroline E. Bass, Ernest F. Terwilliger, R. Christopher Pierce, J. Jang-Ho	135
8	Abstract 3485: MM-111, an ErbB2/ErbB3 bispecific antibody with potent activity in ErbB2-overexpressing cells, positively combines with trastuzumab to inhibit growth of breast cancer cells driven by the ErbB2/ErbB3 oncogenic unit 2010 ·Cancer Research ·Alexandra Huhalov, Sharlene Adams, Violette Paragas, (unknown), Ryan Overland, Lia Luus, Francis D. Gibbons, Bo Zhang, Stephanie A. Nguyen, Ulrik B. Nielsen, Clet Niyikiza, (unknown), Arthur J. Kudla	4
9	MM-111: a novel bispecific antibody targeting ErbB3 with potent anti-tumor activity in ErbB2 over-expressing malignancies. 2009 ·Cancer Research ·Ulrik B. Nielsen, Alexandra Huhalov, Brian D. Harms, Violette Paragas, Sharlene Adams, Jijie Gu, Stephanie A. Nguyen, Lia Luus, (unknown), (unknown), Ryan Overland, (unknown), Neeraj Kohli, Michael J. Feldhaus, Birgit Schoeberl, Charlotte F. McDonagh	6
10	Altered Histone Monoubiquitylation Mediated by Mutant Huntingtin Induces Transcriptional Dysregulation 2008 ·Journal of Neuroscience ·(unknown), (unknown), Ryan Overland, Eva Xia, Ghazaleh Sadri‐Vakili, J. Jang‐Ho	50
11	Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models 2007 ·Human Molecular Genetics ·Ghazaleh Sadri‐Vakili, (unknown), Caroline Benn, (unknown), (unknown), Ryan Overland, Kelly E. Glajch, Eva Xia, Zhihua Qiu, Steven M. Hersch, Tim W. Clark, George J. Yohrling, J. Jang‐Ho	170
12	BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect 2003 ·Nature Medicine ·Andrew R. Hallahan, Joel I. Pritchard, Roshantha A.S. Chandraratna, Richard G. Ellenbogen, (unknown), Ryan Overland, Andrew D. Strand, Stephen J. Tapscott, James M. Olson	156

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact